SF3B1 and hematopoietic and lymphoid system neoplasm: In addition, the SF3B1 mutations in blood cancers destabilize the SF3B1—SUGP1 interaction in humans [40], and their equivalent mutations in the yeast SF3B1-homolog Hsh155 lead to altered Hsh155—Prp5 interaction [38,56].